AR222624A1 - Procedimiento para la preparacion de una formulacion farmaceutica de liberacion prolongada - Google Patents

Procedimiento para la preparacion de una formulacion farmaceutica de liberacion prolongada

Info

Publication number
AR222624A1
AR222624A1 AR262597A AR26259776A AR222624A1 AR 222624 A1 AR222624 A1 AR 222624A1 AR 262597 A AR262597 A AR 262597A AR 26259776 A AR26259776 A AR 26259776A AR 222624 A1 AR222624 A1 AR 222624A1
Authority
AR
Argentina
Prior art keywords
procedure
preparation
pharmaceutical formulation
prolonged release
prolonged
Prior art date
Application number
AR262597A
Other languages
English (en)
Spanish (es)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR7600645A external-priority patent/KR800001387B1/ko
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of AR222624A1 publication Critical patent/AR222624A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AR262597A 1975-03-17 1976-03-17 Procedimiento para la preparacion de una formulacion farmaceutica de liberacion prolongada AR222624A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55910775A 1975-03-17 1975-03-17
US65800376A 1976-02-13 1976-02-13
KR7600645A KR800001387B1 (en) 1975-03-17 1976-03-16 Process for preparing sustained release formulation

Publications (1)

Publication Number Publication Date
AR222624A1 true AR222624A1 (es) 1981-06-15

Family

ID=27348140

Family Applications (1)

Application Number Title Priority Date Filing Date
AR262597A AR222624A1 (es) 1975-03-17 1976-03-17 Procedimiento para la preparacion de una formulacion farmaceutica de liberacion prolongada

Country Status (21)

Country Link
JP (1) JPS51115910A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR222624A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) AT353415B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU505355B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1073358A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH630257A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DD (1) DD124102A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2611041A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK148344C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES446075A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2304354A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1546448A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR60341B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE43083B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
LU (1) LU74558A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MC (1) MC1101A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL190313C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ180321A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PH (1) PH14927A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT64907B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE433804B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
CH649215A5 (de) * 1981-04-29 1985-05-15 Hoffmann La Roche Pharmazeutische praeparate.
CH652025A5 (de) * 1981-09-14 1985-10-31 Hoffmann La Roche Pharmazeutisches praeparat.
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
CH666406A5 (de) * 1984-02-29 1988-07-29 Sandoz Ag Verfahren zur herstellung von mikrokapseln, welche bromokriptinmesylat als pharmakologischen wirkstoff enthalten.
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
WO1985004100A1 (en) * 1984-03-21 1985-09-26 American Home Products Corporation Sustained release pharmaceutical capsules
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
HU195729B (en) * 1985-02-05 1988-07-28 Sandoz Ag Process for producing pharmaceutical compositions containing 9,10-dihydro-ergot-alkaloides
GB8524135D0 (en) * 1985-10-01 1985-11-06 Sandoz Ltd Darodipine compositions
HU197201B (en) * 1985-10-01 1989-03-28 Sandoz Ag Process for producing oral pharmaceutical compositions of controlled solubility of the active components
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
IE64128B1 (en) * 1990-02-26 1995-07-12 Byrne Rynne Holdings Ltd A pharmaceutical composition
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
KR100190254B1 (ko) * 1991-01-30 1999-06-01 레슬리 에드워즈 수-분산성 정제
CA2107678A1 (en) * 1991-04-08 1992-10-09 Kouichi Nakamichi Capsule
ES2124303T3 (es) * 1992-03-25 1999-02-01 Depomed Inc Formas de dosificacion de farmacos orales de liberacion retardada a base de hidroxietilcelulosa.
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
CA2174777A1 (en) * 1993-10-29 1995-05-04 Keith Sugden Gelatin capsule fill able to foam
AU692483B2 (en) * 1993-10-29 1998-06-11 R.P. Scherer Corporation Gelatin capsule fill able to foam
US5888540A (en) * 1993-10-29 1999-03-30 Sugden; Keith Pharmaceutical products
NZ287277A (en) * 1994-05-13 1998-05-27 Smithkline Beecham Corp Oral preparation containing calcium source within a hydrophilic polymer matrix for increasing calcium absorption in the stomach
AU709413B2 (en) * 1994-12-01 1999-08-26 Amarin Development Ab Sustained-release drug delivery employing a powdered hydrocolloid gum obtainable from higher plants
FR2820318B1 (fr) * 2001-02-08 2005-12-23 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant un principe actif et comprime obtenu
FR2820319B3 (fr) * 2001-02-08 2003-12-05 Ellipse Pharmaceuticals Procede de fabrication d'un comprime flottant incluant de l'alfuzosine et comprime obtenu
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
FR2874325B1 (fr) * 2004-08-19 2006-10-20 Sanofi Synthelabo Composition pharmaceutique sous forme de comprime a residence gastrique contenant de l'alfuzosine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1059624B (de) * 1954-11-11 1959-06-18 Dr Knut Jacobus Sundman Verfahren zur Herstellung von in einer Traegersubstanz dispergierten Arzneien in dosierter Form
JPS5512411B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1974-03-12 1980-04-02
DE2439538C3 (de) * 1974-08-17 1980-07-17 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Verfahren zur Herstellung von oral zu verabreichenden Arzneimitteln mit verzögerter Wirkungsfreigabe

Also Published As

Publication number Publication date
GR60341B (en) 1978-05-17
DK113676A (da) 1976-09-18
SE7603325L (sv) 1976-09-18
AT353415B (de) 1979-11-12
NZ180321A (en) 1978-06-20
NL190313C (nl) 1994-01-17
DK148344C (da) 1985-11-04
SE433804B (sv) 1984-06-18
DD124102A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-02-02
IE43083L (en) 1976-09-17
JPS638084B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-02-19
DE2611041A1 (de) 1976-10-14
DE2611041C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-06-09
ES446075A1 (es) 1977-09-16
NL7602776A (nl) 1976-09-21
CA1073358A (en) 1980-03-11
CH630257A5 (en) 1982-06-15
PT64907A (fr) 1976-04-01
IE43083B1 (en) 1980-12-17
FR2304354A1 (fr) 1976-10-15
DK148344B (da) 1985-06-17
PH14927A (en) 1982-01-29
MC1101A1 (fr) 1977-02-04
NL190313B (nl) 1993-08-16
AU1204976A (en) 1977-09-22
ATA192276A (de) 1979-04-15
LU74558A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1977-09-27
AU505355B2 (en) 1979-11-15
JPS51115910A (en) 1976-10-13
GB1546448A (en) 1979-05-23
PT64907B (fr) 1978-03-24
FR2304354B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1979-04-27

Similar Documents

Publication Publication Date Title
AR222624A1 (es) Procedimiento para la preparacion de una formulacion farmaceutica de liberacion prolongada
MX4717E (es) Procedimiento para la preparacion de derivados de pirrolidina
AR215930A1 (es) Procedimiento para la preparacion de compuestos 2-fenil-3-benzoil-benzotiofeno
MX3818E (es) Procedimiento para la preparacion de enaminas de compuestos hidroxi-3-cefem
AR217615A1 (es) Procedimiento para obtener una vacuna para prevencion de la prenez
MX4236E (es) Procedimiento para la preparacion de acidos alcanoicos de heteroarilbenzoxepina
MX4614E (es) Procedimiento mejorado para la preparacion de derivados de pirimidina
MX5119E (es) Procedimiento mejorado para la preparacion de derivados de pirimidona
MX143488A (es) Procedimiento para la preparacion de resorcinas
AR210349A1 (es) Procedimiento para la preparacion de 6-coloro-2(piperacinil)piracina
AR207727A1 (es) Procedimiento y dispositivo para la preparacion de una mezcla particularmente una mezcla fraguable para la construccion
MX5702E (es) Procedimiento para la preparacion de una mezcla de esteroisomeros de alfa-ciano-3-fenoxibencil-2-(4-clorofenil)isovalerato
MX5599E (es) Procedimiento para la preparacion de una composicion farmaceutica a base de trihidrato de amoxicilina
AR212858A1 (es) Procedimiento para la preparacion de derivados farmaceuticamente activos fenipolieno carboxilicos
MX3636E (es) Procedimiento para la preparacion de propargil-2-fenilamino-imidazolinas-(2)
AR213831A1 (es) Procedimiento para la preparacion de 11-desoxi-16-aril-omega-tetranorprostaglandina
AR206336A1 (es) Procedimiento para la preparacion de derivados de 9-(3-(4-fenil-piperazino)-propil)-adenia
MX4133E (es) Procedimiento para la preparacion de n-tetrahidrofurfuril-noroximorfonas diastereoisomeras
AR210453A1 (es) Procedimiento para la preparacion de una 6-alfa-dioxitetraciclina
MX143639A (es) Procedimiento para la preparacion de compuestos disazoicos tetrarreactivos
AR209498A1 (es) Procedimiento para la preparacion de l-piroglutamil-l-pronilamida
MX3789E (es) Procedemiento para la preparacion de una aleacion dental
ES451234A0 (es) Un procedimiento para la preparacion de una composicion de blanqueo.
MX3739E (es) Procedimiento para la preparacion de acilamino-penicilinas-6-substituida
MX3846E (es) Procedimiento para la preparacion de 1-hidrocarburo-3 3-difenil-4-hidroximetil-2-pirrolidinonas